Production of recombinant HIV-1/HBV virus-like particles in Nicotiana tabacum and Arabidopsis thaliana plants for a bivalent plant-based vaccine.

Archive ouverte

Greco, Raffaella | Michel, Marie | Guetard, Denise | Cervantes-Gonzalez, Minerva | Pelucchi, Nilla | Wain-Hobson, Simon | Sala, Francesco | Sala, Monica

Edité par CCSD ; Elsevier -

International audience. Human immunodeficiency virus (HIV-1) and hepatitis B virus (HBV) spread via similar transmission pathways, and infection by HBV occurs in up to 32% of HIV-1 cases. Here, we describe the successful expression of novel recombinant HIV-1/HBV virus-like particles (VLPs) in Nicotiana tabacum and Arabidopsis thaliana. The production levels and quality of the recombinant VLPs were comparable in the two plants, showing that parameters intrinsic to the recombinant proteins determined their assembly into VLPs. These heterologous VLPs can be used in a bivalent anti-HIV-1/-HBV vaccine, administrated via ingestion of transgenic plants.

Consulter en ligne

Suggestions

Du même auteur

Immunogenicity and tolerance following HIV-1/HBV plant-based oral vaccine administration.

Archive ouverte | Guetard, Denise | CCSD

International audience. Transgenic tobacco plants expressing a HIV-1 polyepitope associated with hepatitis B (HBV) virus-like particles (VLPs) were previously described. It is demonstrated here that oral administrat...

Oral administration of low doses of plant-based HBsAg induced antigen-specific IgAs and IgGs in mice, without increasing levels of regulatory T cells.

Archive ouverte | Kostrzak, Anna | CCSD

International audience. Plant-based oral vaccines run the risk of activating regulatory T cells (Tregs) and suppressing the antigen-specific immune response via oral tolerance. Mice humanized for two HLA alleles (HL...

The HIV-1 clade C promoter is particularly well adapted to replication in the gut in primary infection.

Archive ouverte | Centlivre, Mireille | CCSD

International audience. OBJECTIVE: Coinfection of rhesus macaques with human/simian immunodeficiency virus chimeras harbouring the minimal core-promoter/enhancer elements from HIV-1 clade B, C and E viral prototypes...

Chargement des enrichissements...